WO2017168506A1 - SPECIFIC IgE INSPECTION METHOD AND SPECIFIC IgE INSPECTION DEVICE - Google Patents

SPECIFIC IgE INSPECTION METHOD AND SPECIFIC IgE INSPECTION DEVICE Download PDF

Info

Publication number
WO2017168506A1
WO2017168506A1 PCT/JP2016/059881 JP2016059881W WO2017168506A1 WO 2017168506 A1 WO2017168506 A1 WO 2017168506A1 JP 2016059881 W JP2016059881 W JP 2016059881W WO 2017168506 A1 WO2017168506 A1 WO 2017168506A1
Authority
WO
WIPO (PCT)
Prior art keywords
specific ige
test
inspection
allergen
chip
Prior art date
Application number
PCT/JP2016/059881
Other languages
French (fr)
Japanese (ja)
Inventor
内田 剛
仁美 清水
Original Assignee
日立化成株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日立化成株式会社 filed Critical 日立化成株式会社
Priority to JP2018507832A priority Critical patent/JPWO2017168506A1/en
Priority to PCT/JP2016/059881 priority patent/WO2017168506A1/en
Publication of WO2017168506A1 publication Critical patent/WO2017168506A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor

Definitions

  • the present invention relates to a specific IgE inspection method and a specific IgE inspection apparatus.
  • Non-Patent Documents 1 and 2 allergy diagnostic agents and devices capable of simultaneously performing allergy diagnosis related to multiple items of allergens have been studied.
  • specific IgE immunoglobulin
  • the present invention has been made in view of the above, and an object thereof is to provide a specific IgE inspection method and a specific IgE inspection apparatus capable of changing the number of inspection items in accordance with the needs of the user.
  • a specific IgE test method includes a step of bringing a specimen into contact with a plurality of allergens individually immobilized on one test chip, Imaging the region where the allergens of the plurality of items on the test chip are immobilized, optically detecting a reaction between the specimen and the allergen, and the optically detected allergens of the plurality of items
  • the method includes a step of selecting an item to be tested for specific IgE against the allergen, and a step of performing a test on specific IgE against the allergen for the selected item.
  • inspection apparatus which concerns on one form of this invention is the area
  • An imaging unit that optically detects a reaction between the specimen and the allergen, and specific IgE for the allergen among the information on the allergen of the plurality of items optically detected by the imaging unit
  • a test item setting unit that selects an item to be tested, and a test unit that performs a test related to specific IgE against the allergen for the item selected by the test item setting unit.
  • a plurality of allergens immobilized on a test chip are brought into contact with a specimen, and then the plurality of allergens optically detected by imaging are detected. Based on such information, it is possible to set an item to be tested before performing a test related to specific IgE. Therefore, it is possible to perform a test relating to specific IgE only for a preset item. Thus, the number of inspection items can be changed according to the user's needs, and the convenience for the user is improved.
  • the inspection chip may be a flow-through microarray.
  • a chip capable of inspecting a plurality of items can be manufactured with a simpler configuration.
  • the test chip of the once-through microarray can image the reaction results of multiple items of allergen and the sample at a time, the test can be performed more easily.
  • the reaction can be accelerated by increasing the contact opportunities between the allergen and the sample on the surface of the test chip or the complex of the allergen and the sample and the labeled antibody.
  • the inspection chip may have a plurality of reaction regions in which allergens of the same item are immobilized.
  • a specific IgE inspection method and a specific IgE inspection apparatus capable of changing the number of inspection items according to the user's needs.
  • FIG. 1 is a diagram illustrating a specific IgE inspection system including a specific IgE inspection apparatus according to an embodiment of the present invention.
  • the specific IgE test system 1 includes a test chip 2 and a specific IgE test device 3.
  • the specific IgE inspection apparatus 3 includes an imaging unit 31, an inspection item setting unit 32, an inspection unit 33, and an output unit 34.
  • the specific IgE test system 1 is a system that performs a test related to IgE (specific IgE) specific to a substance (allergen) that causes allergy using a specimen O that is a liquid sample derived from serum in blood or the like. It is. By contacting the allergen immobilized on the test chip 2 and the sample O, specific IgE in the sample O is reacted. Thereafter, it is reacted with an enzyme-labeled secondary antibody to form an allergen-specific IgE-enzyme-labeled antibody complex.
  • the amount of specific IgE reacted with the allergen is determined by measuring the amount of light emitted by reacting the complex with a luminescent reagent (for example, luminol and hydrogen peroxide) by the specific IgE test apparatus 3. Since allergens of a plurality of items are immobilized on the test chip 2, it is possible to evaluate the allergens of the plurality of items by a test using the test chip 2.
  • a luminescent reagent for example, luminol and hydrogen peroxide
  • specimen O used in the specific IgE test system 1 examples include blood (whole blood), serum in blood, plasma, and liquid obtained by mixing serum or plasma with a diluent or the like.
  • allergen to be examined is not particularly limited.
  • the inspection chip 2 will be described with reference to FIG. 2A is a plan view of the inspection chip 2, and FIG. 2B is an enlarged view of a part of the inspection chip 2.
  • FIG. 2C is a view of one through-hole 21 in the inspection chip 2 as viewed from above
  • FIG. 2D is a view of the through-hole 21 as viewed from side.
  • the test chip 2 is a plate-like member having a main surface formed of silicon and having a square shape.
  • inspection chip 2 is not specifically limited, Usually used plastics, such as a silicon
  • the term “main component” means that the proportion of the component is 50% by mass or more.
  • the outer shape of the inspection chip 2 is about 3 mm to 15 mm on one side. Further, the thickness of the inspection chip 2 is about 200 ⁇ m to 1 mm.
  • a plurality of through holes 21 are formed in the thickness direction, and allergens are immobilized on the inner surfaces of the plurality of through holes 21. That is, the test chip 2 is a so-called flow-through microarray, and the through hole 21 is a reaction region between the specimen O and the allergen.
  • the shape of the through hole 21 is not particularly limited, for example, as shown in FIGS. 2B and 2C, the cross-sectional shape on the surface orthogonal to the thickness direction can be a square.
  • the shape (cross-sectional shape and shape in the thickness direction) of the inner surface of the through hole 21 is a shape common to the through holes 21.
  • the through-hole 21 of the inspection chip 2 can be, for example, a square with a cross section of 10 ⁇ m on a side and a thickness of 500 ⁇ m.
  • the wall portion 22 that partitions the through holes 21 has a thickness of about 5 ⁇ m.
  • the cross-sectional shape and size of the through hole 21 can be changed as appropriate.
  • the allergen immobilized on the inner surface of the through-hole 21 comes into contact with the specimen O, and specific IgE in the specimen O reacts.
  • the contact area between the allergen and the specimen O is large, the reaction between both is promoted. Therefore, it is preferable to design the cross-sectional area of each through-hole 21 to be small so that the total area of the inner surface of each through-hole 21 is large.
  • the above-described inspection chip 2 can be manufactured by etching using a known semiconductor manufacturing process. By using a method similar to that of the semiconductor manufacturing process, it is possible to provide a very small through-hole 21 adjacently as described above. Moreover, the surface treatment is performed by performing a thermal oxidation treatment after the etching. After the surface treatment is performed, the allergen is immobilized on the inner surface of the through hole 21. The thermal oxidation process is performed as necessary, and is not an essential process.
  • the allergen X is physically adsorbed, electrostatically adsorbed, or chemically immobilized on the entire inner surface of the through hole 21.
  • the method for immobilizing the allergen is not particularly limited as long as it can immobilize the allergen.
  • the test chip 2 different types of allergens are not immobilized in the adjacent through-holes 21, but the same allergen is immobilized on the plurality of through-holes 21 included in a specific region.
  • the through-hole 21 in which one type of allergen is immobilized is designed to be a circular spot region R1 having a diameter of about 100 ⁇ m. That is, allergens of the same item are fixed to the plurality of through holes 21 included in the spot region R1. In the case of this embodiment, about thirty through holes 21 are included.
  • the test chip 2 is provided with a plurality of spot regions R1 to RN (RN is not shown), and different allergens are immobilized for each spot region. Accordingly, the number of items that can be simultaneously inspected by the inspection chip 2 (the number of allergen types) is determined according to the number of spot regions on the inspection chip 2.
  • the light emission from the plurality of through holes 21 included in the spot region R1 is evaluated as one light emission.
  • the amount of light emission to be detected can be increased, so that the detection accuracy is improved.
  • inspection chip 2 you may provide multiple spot area
  • the spot region R1 is between the circular spot region R2 formed by the through-hole 21 on which the allergen of a different type from the allergen of the spot region R1 is immobilized.
  • an interval of about 100 ⁇ m is designed.
  • the spot regions formed by the group of through-holes 21 on which different types of allergens are immobilized are arranged apart from each other, thereby preventing both from mixing. Moreover, the light emission amount for each spot can be accurately measured. The size and interval of the spot area can be changed as appropriate.
  • FIG. 3 shows an example of a pretreatment device that can be used when the specimen O is passed through the through hole 21.
  • the pretreatment device 4 shown in FIG. 3A can be attached to a cylindrical housing 41 having an open top so that the main surface of the inspection chip 2 blocks the cross section of the housing 41. Is.
  • a liquid discharge port 42 is provided below the mounting position of the inspection chip 2 in the housing 41.
  • the sample O is introduced from above the test chip 2 and discharged from the lower discharge port 42, thereby passing the sample O into the through hole 21 of the test chip 2.
  • it is also conceivable that the contact between the allergen and the specimen O is insufficient only by passing the specimen O once through the through hole 21. Therefore, it is desirable to have a configuration in which the passage is repeated many times.
  • FIG. 3B shows an example of a pretreatment device that allows the specimen O to pass through the through hole 21 a plurality of times.
  • the preprocessing device 5 can be attached to a cylindrical casing 51 whose end is closed so that the main surface of the test chip 2 blocks the cross section of the casing 51.
  • a pump P is connected to an end on one side (upper side in the figure), and an inlet 52 and an outlet 53 for the specimen O are provided on the other side (lower side in the figure).
  • the introduction port 52 and the discharge port 53 can be opened and closed by a valve or the like.
  • the sample O is introduced into the housing 51 from the introduction port 52 and then the introduction port 52 is closed, and the suction and discharge in the housing 51 by the pump P are repeated, thereby penetrating.
  • the specimen O reciprocates between one side (upper side in the figure) and the other side (lower side in the figure) in the casing 51 through the hole 21. Thereby, the specimen O can be passed through the through hole 21 of the test chip 2.
  • the pretreatment devices 4 and 5 shown in FIG. 3 can be used when the specimen O is passed through the through-hole 21 and also when the enzyme-labeled secondary antibody and the luminescent reagent are sequentially introduced into the through-hole 21. Can also be used. Note that the pretreatment devices 4 and 5 shown in FIG. 3 are merely examples, and a mechanism different from the pretreatment devices 4 and 5 when the specimen O and other reagents are allowed to pass through the through-hole 21. You may use the apparatus which has.
  • the imaging unit 31 of the specific IgE test apparatus 3 images the test chip 2 that has been processed with the sample O and other reagents as described above, and detects the emission intensity in each spot region.
  • a weak light emission measuring device luminaire
  • CCD Charge-Coupled Device
  • CMOS Complementary MOS
  • the imaging part 31 the light from the test
  • FIG. 4 is a diagram schematically showing information related to the light emission amount for each spot area detected by imaging by the imaging unit 31.
  • the spot regions R1 to RN are shown to become black as the emission intensity increases.
  • the areas corresponding to the spots are indicated by broken lines. In this way, a result in which the light emission amount in the spot region is different is obtained.
  • the test item setting unit 32 has a function of presetting an item (allergen) to be evaluated for the amount of specific IgE based on the amount of luminescence.
  • the item setting may be performed in advance by a user of the specific IgE inspection device 3 before imaging the inspection chip 2, or may be configured by the user setting the item after imaging.
  • the inspection unit 33 calculates the amount of specific IgE based on the amount of luminescence for each item (allergen) set as the inspection target in the inspection item setting unit 32 using the result captured by the imaging unit 31. (Perform quantitative measurement). Furthermore, in the test
  • the output unit 34 outputs the result of the examination related to specific IgE in the examination unit 33.
  • Examples of the output method include a method of displaying on a monitor and the like, a method of transmitting to an external device such as a printer, and the like.
  • the inspection item setting unit 32, the inspection unit 33, and the output unit 34 of the specific IgE inspection device 3 are a CPU (Central Processing Unit), a RAM (Random Access Memory) and a ROM (Read Only Memory) that are main storage devices, and others.
  • a computer including a communication module that performs communication with other devices and hardware such as an auxiliary storage device such as a hard disk can be configured. When these components operate, functions as the test item setting unit 32, the test unit 33, and the output unit 34 of the specific IgE test apparatus 3 are exhibited.
  • the specific IgE test method using the specific IgE test system 1 described above includes a step of bringing a specimen into contact with a plurality of allergens individually immobilized on one test chip, and a plurality of test chip chips. Imaging the region where the allergen of the item is immobilized, optically detecting the reaction between the specimen and the allergen, and among the information on the optically detected allergen of the plurality of items, specific IgE for the allergen
  • the method includes a step of selecting an item to be tested, and a step of performing a test on specific IgE against allergen for the selected item. A specific procedure will be described with reference to FIG.
  • an item to be inspected is selected by a user or the like (S01).
  • the specimen O and the test chip 2 are brought into contact with each other using the pretreatment device 4 or the like, and the specimen O is introduced into the through hole 21 (S02).
  • the sample O and the allergen in the through-hole 21 contact.
  • the secondary antibody and the luminescent reagent are sequentially passed through the through-hole 21 after the specimen O has passed, thereby performing a process of emitting specific IgE reacted with the allergen (S03).
  • the test chip 2 in which the light emission amount changes for each spot region is imaged by the imaging unit 31 of the specific IgE inspection device 3, and the light emission amount for each spot region is detected (S04).
  • the inspection unit 33 for the item (allergen) set as the inspection object in the inspection item setting unit 32, an inspection related to specific IgE including calculation of the amount of specific IgE based on the amount of luminescence is performed (S05). ).
  • the inspection result is output from the output unit 34 (S06). Thereby, a series of operations related to the examination of specific IgE is completed.
  • the test item setting unit 32 sets the items to be tested in advance before the test unit 33 performs the test related to the specific IgE against the allergen. And in the test
  • a diagnostic method using such a diagnostic agent is useful for screening causal allergens of patients with allergic diseases because it can perform tests related to allergens of multiple items at once.
  • the specific IgE test system 1 including the specific IgE test apparatus 3 and the specific IgE test method according to the present embodiment
  • the items to be inspected can be set in advance in the inspection item setting unit 32.
  • the inspection unit 33 can perform an inspection related to specific IgE for allergens only for the items set in the inspection item setting unit 32.
  • the number of inspection items can be changed according to the user's needs, and the convenience for the user is improved.
  • the target item can be selected on the side of the specific IgE inspection apparatus 3, so that the inspection can be performed using the same inspection chip 2. Therefore, it is not necessary to manufacture the inspection chip 2 according to the user, and a configuration for changing the number of inspection items or the inspection items according to the user's needs can be realized at a lower cost.
  • a chip capable of performing inspections related to a plurality of items is manufactured with a simpler configuration. can do.
  • the cross-flow configuration increases the chance of contact between the allergen on the surface of the test chip and the sample, or between the allergen-sample complex and the labeled antibody, thereby accelerating the reaction. can do.
  • the flow-through microarray test chip 2 can capture the reaction results of multiple items of allergens and the sample O at once by the imaging unit 31 of the specific IgE test apparatus 3, the test is performed more easily. be able to.
  • the above-described inspection chip 2 has a plurality of spot regions constituted by a plurality of through holes 21 to which allergens of the same item are immobilized.
  • the inspection chip 2 is a once-through microarray has been described, but the shape of the inspection chip 2 can be changed as appropriate.
  • the configuration of the test chip 2 can be changed as appropriate as long as at least a plurality of allergens are immobilized and the specimen O and the allergen can contact each other.
  • a configuration that can be used as an inspection chip in a shape different from that of the once-through microarray for example, a chip in which a plurality of allergens are immobilized on a flat substrate is used as the inspection chip according to the present embodiment.
  • a chip in which a plurality of allergens are immobilized on a substrate having an uneven surface can be used as the inspection chip according to the present embodiment.
  • the configuration in which the setting of the inspection item is performed before the imaging of the inspection chip 2 has been described.
  • the configuration may be such that the inspection item is set (selected) after the imaging of the inspection chip 2.
  • the inspection related to specific IgE using the information is repeated. Can be done. In such a case, for example, only a representative allergen is evaluated as a screening stage, and at a stage where the field of a substance that is assumed to be an allergen can be narrowed to some extent, the evaluation related to the allergen in the relevant field is made more detailed. It is also possible. In this way, the timing for setting the inspection item can be changed as appropriate.
  • the reaction between the allergen and the specific IgE of the specimen O is measured as the amount of luminescence using a luminescent reagent.
  • the measurement is performed using a fluorescent reagent or the like. It may be changed. That is, the reaction between the allergen and the specific IgE of the specimen O can be appropriately changed within a range that can be detected optically.
  • the imaging unit 31 may have a light source.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

This specific IgE inspection method has a step for causing a specimen to come into contact with a plurality of items of allergens that are each individually fixed to a single inspection chip, a step for imaging the area of the inspection chip to which the plurality of items of allergens have been fixed and optically detecting reactions between the specimen and allergens, a step for selecting items on which to carry out specific IgE inspection from among the information for the plurality of items of allergens subjected to optical detection, and a step for carrying out specific IgE inspection on the selected items.

Description

特異的IgE検査方法及び特異的IgE検査装置Specific IgE test method and specific IgE test device
 本発明は、特異的IgE検査方法及び特異的IgE検査装置に関する。 The present invention relates to a specific IgE inspection method and a specific IgE inspection apparatus.
 アレルギーに対する治療方針を立てる場合には、多種多様なアレルゲンの中から、患者が感作しているアレルゲンを特定することが重要である。そのため、非特許文献1,2に示すように、多項目のアレルゲンに係るアレルギー診断を同時に行うことが可能なアレルギー診断薬及び装置が検討されている。非特許文献1,2に記載のアレルギー診断薬及び装置では、アレルゲンに対応した特異的IgE(免疫グロブリン)を測定し、アレルギーに関する診断が行われる。 When making a treatment policy for allergies, it is important to identify allergens that the patient is sensitizing from among allergens. Therefore, as shown in Non-Patent Documents 1 and 2, allergy diagnostic agents and devices capable of simultaneously performing allergy diagnosis related to multiple items of allergens have been studied. In the allergy diagnostic drug and apparatus described in Non-Patent Documents 1 and 2, specific IgE (immunoglobulin) corresponding to the allergen is measured, and diagnosis for allergy is performed.
 患者への負荷を増加させることなくアレルゲンの同定を行おうとすると、同時により多くのアレルゲンに対応した特異的IgEの検査を行うことが求められる。一方で、特異的IgEに係る検査を行う項目を限定して検査を行いたいという現場でのニーズも存在する。 When trying to identify allergens without increasing the load on the patient, it is required to test specific IgE corresponding to more allergens at the same time. On the other hand, there is a need in the field where it is desired to limit the items to be tested for specific IgE.
 本発明は、上記を鑑みてなされたものであり、ユーザのニーズに応じて検査項目数を変更することが可能な特異的IgE検査方法及び特異的IgE検査装置を提供することを目的とする。 The present invention has been made in view of the above, and an object thereof is to provide a specific IgE inspection method and a specific IgE inspection apparatus capable of changing the number of inspection items in accordance with the needs of the user.
 上記目的を達成するため、本発明の一形態に係る特異的IgE検査方法は、1つの検査チップに対して個別に固定化された複数項目のアレルゲンに対して、検体を接触させる工程と、前記検査チップにおける前記複数項目の前記アレルゲンが固定化された領域を撮像し、前記検体と前記アレルゲンとの反応を光学的に検出する工程と、前記光学的に検出された前記複数項目の前記アレルゲンに係る情報のうち、前記アレルゲンに対する特異的IgEに係る検査を行う項目を選択する工程と、前記選択された項目について、前記アレルゲンに対する特異的IgEに係る検査を行う工程と、を有する。 In order to achieve the above object, a specific IgE test method according to an aspect of the present invention includes a step of bringing a specimen into contact with a plurality of allergens individually immobilized on one test chip, Imaging the region where the allergens of the plurality of items on the test chip are immobilized, optically detecting a reaction between the specimen and the allergen, and the optically detected allergens of the plurality of items Of such information, the method includes a step of selecting an item to be tested for specific IgE against the allergen, and a step of performing a test on specific IgE against the allergen for the selected item.
 また、本発明の一形態に係る特異的IgE検査装置は、個別に固定化された複数項目のアレルゲンのそれぞれに対して検体を接触させた検査チップにおける前記複数項目のアレルゲンが固定化された領域を撮像し、前記検体と前記アレルゲンとの反応を光学的に検出する撮像部と、前記撮像部により光学的に検出された前記複数項目の前記アレルゲンに係る情報のうち、前記アレルゲンに対する特異的IgEに係る検査を行う項目を選択する検査項目設定部と、前記検査項目設定部により選択された項目について、前記アレルゲンに対する特異的IgEに係る検査を行う検査部と、を備える。 Moreover, the specific IgE test | inspection apparatus which concerns on one form of this invention is the area | region where the said several item allergen was fixed in the test | inspection chip which contacted the specimen with respect to each of the several item allergen fixed individually. An imaging unit that optically detects a reaction between the specimen and the allergen, and specific IgE for the allergen among the information on the allergen of the plurality of items optically detected by the imaging unit A test item setting unit that selects an item to be tested, and a test unit that performs a test related to specific IgE against the allergen for the item selected by the test item setting unit.
 上記の特異的IgE検査方法及び特異的IgE検査装置によれば、検査チップに固定化された複数項目のアレルゲンと検体とを接触させた後、撮像により光学的に検出された複数項目のアレルゲンに係る情報に基づいて、特異的IgEに係る検査を行う前に、検査を行う項目を設定することが可能となる。したがって、予め設定された項目についてのみ特異的IgEに係る検査を行うことができる。このように、ユーザのニーズに応じて検査項目数を変更することが可能となり、ユーザの利便性が向上する。 According to the specific IgE test method and the specific IgE test apparatus described above, a plurality of allergens immobilized on a test chip are brought into contact with a specimen, and then the plurality of allergens optically detected by imaging are detected. Based on such information, it is possible to set an item to be tested before performing a test related to specific IgE. Therefore, it is possible to perform a test relating to specific IgE only for a preset item. Thus, the number of inspection items can be changed according to the user's needs, and the convenience for the user is improved.
 ここで、前記検査チップは、貫流型マイクロアレイである態様とすることができる。 Here, the inspection chip may be a flow-through microarray.
 上記のように、検査チップとして貫流型マイクロアレイを採用することにより、複数の項目に係る検査を行うことができるチップをより単純な構成で製造することができる。また、貫流型マイクロアレイの検査チップは、多項目のアレルゲンと検体との反応結果を一度に撮像することができることから、検査をより簡便に行うことができる。さらに、貫流型とすることで、検査チップ表面のアレルゲンと検体、あるいはアレルゲンと検体との複合体と標識抗体との接触機会を増やすことで反応を加速することができる。 As described above, by adopting a once-through microarray as an inspection chip, a chip capable of inspecting a plurality of items can be manufactured with a simpler configuration. In addition, since the test chip of the once-through microarray can image the reaction results of multiple items of allergen and the sample at a time, the test can be performed more easily. Furthermore, by using the flow-through type, the reaction can be accelerated by increasing the contact opportunities between the allergen and the sample on the surface of the test chip or the complex of the allergen and the sample and the labeled antibody.
 また、前記検査チップは、同一項目のアレルゲンが固定化された反応領域を複数有する態様とすることができる。 Further, the inspection chip may have a plurality of reaction regions in which allergens of the same item are immobilized.
 上記のように、同一項目のアレルゲンが固定化された反応領域を複数有することで、複数の反応領域の結果に基づいて、アレルゲンに対する特異的IgEに係る検査結果を求める構成とすることが可能となり、検査結果の誤りを防ぐことが可能となる。 As described above, by having a plurality of reaction regions in which allergens of the same item are immobilized, it is possible to obtain a test result related to specific IgE for allergens based on the results of the plurality of reaction regions. It is possible to prevent an error in the inspection result.
 本発明によれば、ユーザのニーズに応じて検査項目数を変更することが可能な特異的IgE検査方法及び特異的IgE検査装置が提供される。 According to the present invention, there are provided a specific IgE inspection method and a specific IgE inspection apparatus capable of changing the number of inspection items according to the user's needs.
本発明の実施形態に係る特異的IgE検査装置を含む特異的IgE検査システムを説明する図である。It is a figure explaining the specific IgE test | inspection system containing the specific IgE test | inspection apparatus which concerns on embodiment of this invention. 検査チップの構造を説明する図である。It is a figure explaining the structure of a test | inspection chip. 前処理用デバイスの概略構成を説明する図である。It is a figure explaining schematic structure of the device for pretreatment. 検査チップにおける反応の一例を説明する図である。It is a figure explaining an example of reaction in a test chip. 本発明の実施形態に係る特異的IgE検査方法を説明するフロー図である。It is a flowchart explaining the specific IgE inspection method which concerns on embodiment of this invention.
 以下、添付図面を参照して、本発明を実施するための形態を詳細に説明する。なお、図面の説明においては同一要素には同一符号を付し、重複する説明を省略する。 Hereinafter, embodiments for carrying out the present invention will be described in detail with reference to the accompanying drawings. In the description of the drawings, the same elements are denoted by the same reference numerals, and redundant description is omitted.
 図1は、本発明の一実施形態に係る特異的IgE検査装置を含む特異的IgE検査システムを説明する図である。図1に示すように、特異的IgE検査システム1は、検査チップ2と、特異的IgE検査装置3と、を含む。また、特異的IgE検査装置3は、撮像部31と、検査項目設定部32と、検査部33と、出力部34と、を有する。 FIG. 1 is a diagram illustrating a specific IgE inspection system including a specific IgE inspection apparatus according to an embodiment of the present invention. As shown in FIG. 1, the specific IgE test system 1 includes a test chip 2 and a specific IgE test device 3. Further, the specific IgE inspection apparatus 3 includes an imaging unit 31, an inspection item setting unit 32, an inspection unit 33, and an output unit 34.
 特異的IgE検査システム1は、血液中の血清等に由来する液体試料である検体Oを用いてアレルギーの原因となる物質(アレルゲン)に特異的なIgE(特異的IgE)に係る検査を行うシステムである。検査チップ2に固定化されているアレルゲンと、検体Oとを接触させることで、検体O中の特異的IgEを反応させる。その後、酵素標識した二次抗体と反応させることで、アレルゲン-特異的IgE-酵素標識抗体の複合体を形成させる。そして、特異的IgE検査装置3によって、複合体と発光試薬(例えば、ルミノール及び過酸化水素)とを反応させることによる発光量を測定することで、アレルゲンと反応した特異的IgEの量を求める。検査チップ2には、複数項目のアレルゲンが固定化されているため、検査チップ2を用いた検査により、複数項目のアレルゲンに係る評価を行うことが可能である。 The specific IgE test system 1 is a system that performs a test related to IgE (specific IgE) specific to a substance (allergen) that causes allergy using a specimen O that is a liquid sample derived from serum in blood or the like. It is. By contacting the allergen immobilized on the test chip 2 and the sample O, specific IgE in the sample O is reacted. Thereafter, it is reacted with an enzyme-labeled secondary antibody to form an allergen-specific IgE-enzyme-labeled antibody complex. Then, the amount of specific IgE reacted with the allergen is determined by measuring the amount of light emitted by reacting the complex with a luminescent reagent (for example, luminol and hydrogen peroxide) by the specific IgE test apparatus 3. Since allergens of a plurality of items are immobilized on the test chip 2, it is possible to evaluate the allergens of the plurality of items by a test using the test chip 2.
 特異的IgE検査システム1に用いられる検体Oとしては、血液(全血)、血液中の血清、血漿、及び、血清又は血漿に対して希釈液等を混合した液体等が挙げられる。また、検査対象となるアレルゲンは特に限定されない。 Examples of the specimen O used in the specific IgE test system 1 include blood (whole blood), serum in blood, plasma, and liquid obtained by mixing serum or plasma with a diluent or the like. Moreover, the allergen to be examined is not particularly limited.
 検査チップ2について、図2を参照しながら説明する。図2(A)は、検査チップ2の平面図であり、図2(B)は、検査チップ2の一部を拡大した図である。また、図2(C)は、検査チップ2における1つの貫通孔21を上面から見た図であり、図2(D)は、貫通孔21を側面から見た図である。検査チップ2は、図1、及び、図2(A)に示すように、シリコンにより形成された主面が正方形状の板状の部材である。検査チップ2の材質は特に限定されないが、シリコン、ポリスチレン等の通常用いられるプラスチック類を主成分として用いることができる。また、網目構造を有するナイロン、ポリプロピレン等の樹脂材料を検査チップ2として用いることもできる。なお、「主成分」であるとは、当該成分の占める割合が50質量%以上であることをいう。 The inspection chip 2 will be described with reference to FIG. 2A is a plan view of the inspection chip 2, and FIG. 2B is an enlarged view of a part of the inspection chip 2. FIG. 2C is a view of one through-hole 21 in the inspection chip 2 as viewed from above, and FIG. 2D is a view of the through-hole 21 as viewed from side. As shown in FIGS. 1 and 2A, the test chip 2 is a plate-like member having a main surface formed of silicon and having a square shape. Although the material of the test | inspection chip 2 is not specifically limited, Usually used plastics, such as a silicon | silicone and a polystyrene, can be used as a main component. Also, a resin material such as nylon or polypropylene having a network structure can be used as the inspection chip 2. The term “main component” means that the proportion of the component is 50% by mass or more.
 検査チップ2の外形は、一辺が3mm~15mm程度である。また、検査チップ2の厚さは200μm~1mm程度である。 The outer shape of the inspection chip 2 is about 3 mm to 15 mm on one side. Further, the thickness of the inspection chip 2 is about 200 μm to 1 mm.
 また、検査チップ2には、複数の貫通孔21が厚さ方向に形成されていて、複数の貫通孔21それぞれの内面にアレルゲンが固定化される。すなわち、検査チップ2は、所謂貫流型マイクロアレイであり、貫通孔21が、検体Oとアレルゲンとの反応領域となる。貫通孔21の形状は特に限定されないが、例えば、図2(B),(C)に示すように、厚さ方向に直交する面での断面形状を正方形とすることができる。 In the inspection chip 2, a plurality of through holes 21 are formed in the thickness direction, and allergens are immobilized on the inner surfaces of the plurality of through holes 21. That is, the test chip 2 is a so-called flow-through microarray, and the through hole 21 is a reaction region between the specimen O and the allergen. Although the shape of the through hole 21 is not particularly limited, for example, as shown in FIGS. 2B and 2C, the cross-sectional shape on the surface orthogonal to the thickness direction can be a square.
 また、貫通孔21の内面の形状(断面形状及び厚さ方向の形状)は、貫通孔21間で共通した形状であることが好ましい。貫通孔21間での内壁形状を共通とすることで、特異的IgEに係る検査の精度を向上させることができる。 Further, it is preferable that the shape (cross-sectional shape and shape in the thickness direction) of the inner surface of the through hole 21 is a shape common to the through holes 21. By making the inner wall shape between the through holes 21 common, it is possible to improve the accuracy of the inspection related to specific IgE.
 検査チップ2の貫通孔21は、例えば、断面を一辺10μmの正方形とし、厚さを500μmとすることができる。貫通孔21同士を区画する壁部22は厚さが5μm程度である。貫通孔21の断面形状及びその大きさは適宜変更することができる。ただし、貫通孔21内を検体Oが通過することにより、貫通孔21の内面に固定化されたアレルゲンと検体Oとが接触し、検体O中の特異的IgEが反応する。アレルゲンと検体Oとの接触面積が大きいと両者の反応が促進されるので、各貫通孔21における内面の総面積が大きくなるように、各貫通孔21の断面積を小さく設計することが好ましい。 The through-hole 21 of the inspection chip 2 can be, for example, a square with a cross section of 10 μm on a side and a thickness of 500 μm. The wall portion 22 that partitions the through holes 21 has a thickness of about 5 μm. The cross-sectional shape and size of the through hole 21 can be changed as appropriate. However, when the specimen O passes through the through-hole 21, the allergen immobilized on the inner surface of the through-hole 21 comes into contact with the specimen O, and specific IgE in the specimen O reacts. When the contact area between the allergen and the specimen O is large, the reaction between both is promoted. Therefore, it is preferable to design the cross-sectional area of each through-hole 21 to be small so that the total area of the inner surface of each through-hole 21 is large.
 上記の検査チップ2は、公知の半導体製造プロセスを利用したエッチング等により製造することができる。半導体製造プロセスと同様の手法を用いることで、上記のように非常に小さな貫通孔21を隣接して設けることが可能となる。また、エッチングの後に熱酸化処理を行うことで、表面の処理が行われる。表面処理が行われた後に、貫通孔21の内面にアレルゲンが固定化される。なお、熱酸化処理は必要に応じて行われるものであり、必須の処理ではない。 The above-described inspection chip 2 can be manufactured by etching using a known semiconductor manufacturing process. By using a method similar to that of the semiconductor manufacturing process, it is possible to provide a very small through-hole 21 adjacently as described above. Moreover, the surface treatment is performed by performing a thermal oxidation treatment after the etching. After the surface treatment is performed, the allergen is immobilized on the inner surface of the through hole 21. The thermal oxidation process is performed as necessary, and is not an essential process.
 図2(C),(D)に示すように、アレルゲンXは、貫通孔21の内面全面に対して、物理吸着(physisorption)、静電的な吸着、又は化学的に固定化される。アレルゲンの固定化方法は、アレルゲンを固定可能な方法であれば、特に限定されない。 As shown in FIGS. 2C and 2D, the allergen X is physically adsorbed, electrostatically adsorbed, or chemically immobilized on the entire inner surface of the through hole 21. The method for immobilizing the allergen is not particularly limited as long as it can immobilize the allergen.
 検査チップ2では、隣接する貫通孔21において互いに異なる種類のアレルゲンが固定化されるのではなく、特定の領域に含まれる複数の貫通孔21に対して同一のアレルゲンが固定化される。図2に示す検査チップ2の場合、一種類のアレルゲンが内部に固定化された貫通孔21が、直径が100μm程度の円状のスポット領域R1となるように設計される。つまり、スポット領域R1に含まれる複数の貫通孔21には、同一項目のアレルゲンが固定化される。本実施形態の場合、30個程度の貫通孔21が含まれる。また、検査チップ2には、複数のスポット領域R1~RN(RNは図示省略している)が設けられ、スポット領域毎に互いに異なるアレルゲンが固定化される。したがって、検査チップ2で同時に検査可能な項目の数(アレルゲンの種類の数)は、検査チップ2におけるスポットの領域の数に応じて決められる。 In the test chip 2, different types of allergens are not immobilized in the adjacent through-holes 21, but the same allergen is immobilized on the plurality of through-holes 21 included in a specific region. In the case of the test chip 2 shown in FIG. 2, the through-hole 21 in which one type of allergen is immobilized is designed to be a circular spot region R1 having a diameter of about 100 μm. That is, allergens of the same item are fixed to the plurality of through holes 21 included in the spot region R1. In the case of this embodiment, about thirty through holes 21 are included. The test chip 2 is provided with a plurality of spot regions R1 to RN (RN is not shown), and different allergens are immobilized for each spot region. Accordingly, the number of items that can be simultaneously inspected by the inspection chip 2 (the number of allergen types) is determined according to the number of spot regions on the inspection chip 2.
 発光量の評価を行う際には、スポット領域R1に含まれる複数の貫通孔21での発光をまとめた1つの発光として評価する。複数の貫通孔21での発光を1つの発光として評価することで、検出する発光量を大きくすることができるため、検出精度が向上する。また、検査チップ2においては、同一項目のアレルゲンが固定化された複数の貫通孔21から構成されるスポット領域を複数備えていてもよい。例えば、隣接する4つ(2×2)のスポット領域を同一項目のアレルゲンによる検査に用いる構成としてもよい。その場合には、複数のスポット領域における検査結果をふまえて特異的IgEに係る結果を求める構成とすることができ、より精度よく検査結果を求めることができると共に検査結果の誤りを防ぐことが可能となる。 When evaluating the light emission amount, the light emission from the plurality of through holes 21 included in the spot region R1 is evaluated as one light emission. By evaluating the light emission from the plurality of through holes 21 as one light emission, the amount of light emission to be detected can be increased, so that the detection accuracy is improved. Moreover, in the test | inspection chip 2, you may provide multiple spot area | regions comprised from the several through-hole 21 to which the allergen of the same item was fix | immobilized. For example, it is good also as a structure used for the test | inspection by the allergen of the same item of four adjacent (2x2) spot areas. In that case, it is possible to obtain a result related to specific IgE based on the test results in a plurality of spot regions, and it is possible to obtain the test result more accurately and to prevent an error in the test result. It becomes.
 また、図2(B)に示すように、スポット領域R1は、スポット領域R1のアレルゲンとは別の種類のアレルゲンが固定化される貫通孔21により形成される円状のスポット領域R2との間に、100μm程度の間隔が設けられるように設計される。このように、互いに異なる種類のアレルゲンが固定化された貫通孔21群によって形成されるスポット領域同士が離間して配置されることで、両者が混合することを防ぐことができる。また、スポット毎の発光量を精度よく測定することができる。スポット領域の大きさ及び間隔等については、適宜変更することができる。 In addition, as shown in FIG. 2 (B), the spot region R1 is between the circular spot region R2 formed by the through-hole 21 on which the allergen of a different type from the allergen of the spot region R1 is immobilized. In addition, an interval of about 100 μm is designed. As described above, the spot regions formed by the group of through-holes 21 on which different types of allergens are immobilized are arranged apart from each other, thereby preventing both from mixing. Moreover, the light emission amount for each spot can be accurately measured. The size and interval of the spot area can be changed as appropriate.
 検査チップ2の貫通孔21に固定化されたアレルゲンと検体Oと接触させるためには、貫通孔21内に検体Oを通過させる必要がある。貫通孔21内に検体Oを通過させる方法は特に限定されないが、貫通孔21内に検体Oを通過させる際に用いることができる前処理用デバイスの例を図3に示す。 In order to bring the allergen immobilized in the through hole 21 of the test chip 2 into contact with the specimen O, the specimen O needs to pass through the through hole 21. A method for allowing the specimen O to pass through the through hole 21 is not particularly limited, but FIG. 3 shows an example of a pretreatment device that can be used when the specimen O is passed through the through hole 21.
 図3(A)に示す前処理用デバイス4は、上方が開口した筒型の筐体41に対して、検査チップ2の主面が筐体41の断面を塞ぐように取り付け可能となっているものである。また、筐体41における検査チップ2の取付位置よりも下方には液体の排出口42が設けられている。このような前処理用デバイス4を用いる場合には、検査チップ2の上方から検体Oを投入し、下方の排出口42から排出することで、検査チップ2の貫通孔21内に検体Oを通過させることができる。ただし、貫通孔21内に検体Oを一度通過させただけでは、アレルゲンと検体Oとの接触が不十分であることも考えられる。したがって、何度も繰り返し通過させる構成とすることが望まれる。 The pretreatment device 4 shown in FIG. 3A can be attached to a cylindrical housing 41 having an open top so that the main surface of the inspection chip 2 blocks the cross section of the housing 41. Is. A liquid discharge port 42 is provided below the mounting position of the inspection chip 2 in the housing 41. When such a pretreatment device 4 is used, the sample O is introduced from above the test chip 2 and discharged from the lower discharge port 42, thereby passing the sample O into the through hole 21 of the test chip 2. Can be made. However, it is also conceivable that the contact between the allergen and the specimen O is insufficient only by passing the specimen O once through the through hole 21. Therefore, it is desirable to have a configuration in which the passage is repeated many times.
 図3(B)は、貫通孔21内に検体Oを複数回通過させることが可能な前処理用デバイスの例である。前処理用デバイス5は、端部が閉じた筒型の筐体51に対して、検査チップ2の主面が筐体51の断面を塞ぐように取り付け可能となっているものである。そして、一方側(図示上方)の端部にはポンプPが連結されると共に、他方側(図示下方)の端部には検体Oの導入口52及び排出口53が設けられる。導入口52及び排出口53はバルブ等により開閉可能とされている。このような前処理用デバイス5では、導入口52から筐体51内に検体Oを導入した後に導入口52を閉とし、ポンプPによる筐体51内の吸引と排出とを繰り返すことで、貫通孔21を経て検体Oが筐体51内の一方側(図示上方)と他方側(図示下方)とを往復させる。これにより、検査チップ2の貫通孔21内に検体Oを通過させることができる。 FIG. 3B shows an example of a pretreatment device that allows the specimen O to pass through the through hole 21 a plurality of times. The preprocessing device 5 can be attached to a cylindrical casing 51 whose end is closed so that the main surface of the test chip 2 blocks the cross section of the casing 51. A pump P is connected to an end on one side (upper side in the figure), and an inlet 52 and an outlet 53 for the specimen O are provided on the other side (lower side in the figure). The introduction port 52 and the discharge port 53 can be opened and closed by a valve or the like. In such a pretreatment device 5, the sample O is introduced into the housing 51 from the introduction port 52 and then the introduction port 52 is closed, and the suction and discharge in the housing 51 by the pump P are repeated, thereby penetrating. The specimen O reciprocates between one side (upper side in the figure) and the other side (lower side in the figure) in the casing 51 through the hole 21. Thereby, the specimen O can be passed through the through hole 21 of the test chip 2.
 図3で示した前処理用デバイス4,5は、貫通孔21に検体Oを通過させる場合に用いることができるほか、酵素標識した二次抗体及び発光試薬を順に貫通孔21内に導入する際にも用いることができる。なお、図3で示した前処理用デバイス4,5はあくまで一例であり、貫通孔21に対して検体O及びその他の試薬等を通過させる場合に、前処理用デバイス4,5とは異なる機構を有する装置を用いてもよい。 The pretreatment devices 4 and 5 shown in FIG. 3 can be used when the specimen O is passed through the through-hole 21 and also when the enzyme-labeled secondary antibody and the luminescent reagent are sequentially introduced into the through-hole 21. Can also be used. Note that the pretreatment devices 4 and 5 shown in FIG. 3 are merely examples, and a mechanism different from the pretreatment devices 4 and 5 when the specimen O and other reagents are allowed to pass through the through-hole 21. You may use the apparatus which has.
 図1に戻り、特異的IgE検査装置3について説明する。特異的IgE検査装置3の撮像部31は、上記のように検体O及びその他の試薬による処理が終了した検査チップ2を撮像し、各スポット領域での発光強度を検出する。撮像部31としては、微弱発光測定装置(ルミノメーター)、CCD(Charge-Coupled Device)イメージセンサ、CMOS(Complementary MOS)イメージセンサ等を用いることができる。撮像部31では、受光画素が2次元に配置された受光面において、検査チップ2からの光を受光する。その後、受光面における受光により発生する電荷をA/D変換器によりデジタル変換し、各画素における光の受光強度の分布を示すデジタル情報を生成する。これにより、検査チップ2の各位置における発光量に係る情報が取得される。 Referring back to FIG. 1, the specific IgE inspection apparatus 3 will be described. The imaging unit 31 of the specific IgE test apparatus 3 images the test chip 2 that has been processed with the sample O and other reagents as described above, and detects the emission intensity in each spot region. As the imaging unit 31, a weak light emission measuring device (luminometer), a CCD (Charge-Coupled Device) image sensor, a CMOS (Complementary MOS) image sensor, or the like can be used. In the imaging part 31, the light from the test | inspection chip 2 is light-received in the light-receiving surface where a light-receiving pixel is arrange | positioned two-dimensionally. Thereafter, charges generated by light reception on the light receiving surface are digitally converted by an A / D converter, and digital information indicating a distribution of light reception intensity of light in each pixel is generated. Thereby, the information regarding the light emission amount in each position of the test | inspection chip 2 is acquired.
 図4は、撮像部31による撮像によって検出されるスポット領域毎の発光量に係る情報を模式的に示した図である。図4では、スポット領域R1~RNについて、発光強度が大きいほど黒くなるように示している。また、発光が検出されなかったスポット領域についてはスポットに対応する領域を破線で示している。このように、スポット領域における発光量が異なる結果が得られる。 FIG. 4 is a diagram schematically showing information related to the light emission amount for each spot area detected by imaging by the imaging unit 31. In FIG. 4, the spot regions R1 to RN are shown to become black as the emission intensity increases. For spot areas where no light emission is detected, the areas corresponding to the spots are indicated by broken lines. In this way, a result in which the light emission amount in the spot region is different is obtained.
 検査項目設定部32は、発光量に基づいて、特異的IgEの量を評価する対象となる項目(アレルゲン)を予め設定する機能を有する。項目の設定は、検査チップ2の撮像前に特異的IgE検査装置3のユーザ等によって予め行われる態様としてもよいし、撮像後にユーザが項目を設定する態様としてもよい。 The test item setting unit 32 has a function of presetting an item (allergen) to be evaluated for the amount of specific IgE based on the amount of luminescence. The item setting may be performed in advance by a user of the specific IgE inspection device 3 before imaging the inspection chip 2, or may be configured by the user setting the item after imaging.
 検査部33は、撮像部31において撮像された結果を利用して、検査項目設定部32において検査対象として設定された項目(アレルゲン)について、それぞれ発光量に基づいて特異的IgEの量を算出する(定量測定を行う)。さらに、検査部33において、算出されたアレルゲンに係る特異的IgEの量に応じてランクを当てはめる等の処理を行う構成としてもよい。 The inspection unit 33 calculates the amount of specific IgE based on the amount of luminescence for each item (allergen) set as the inspection target in the inspection item setting unit 32 using the result captured by the imaging unit 31. (Perform quantitative measurement). Furthermore, in the test | inspection part 33, it is good also as a structure which performs the process of applying a rank etc. according to the quantity of the specific IgE which concerns on the calculated allergen.
 出力部34は、検査部33における特異的IgEに係る検査を行った結果を出力する。出力方法としては、モニタ等に表示する方法、プリンタ等の外部装置に対して送信する方法等が挙げられる。 The output unit 34 outputs the result of the examination related to specific IgE in the examination unit 33. Examples of the output method include a method of displaying on a monitor and the like, a method of transmitting to an external device such as a printer, and the like.
 特異的IgE検査装置3の検査項目設定部32、検査部33、及び出力部34は、CPU(Central Processing Unit)、主記憶装置であるRAM(Random Access Memory)及びROM(Read Only Memory)、他の機器との間の通信を行う通信モジュール、並びにハードディスク等の補助記憶装置等のハードウェアを備えるコンピュータを含んで構成することができる。そして、これらの構成要素が動作することにより、特異的IgE検査装置3の検査項目設定部32、検査部33、及び出力部34としての機能が発揮される。 The inspection item setting unit 32, the inspection unit 33, and the output unit 34 of the specific IgE inspection device 3 are a CPU (Central Processing Unit), a RAM (Random Access Memory) and a ROM (Read Only Memory) that are main storage devices, and others. A computer including a communication module that performs communication with other devices and hardware such as an auxiliary storage device such as a hard disk can be configured. When these components operate, functions as the test item setting unit 32, the test unit 33, and the output unit 34 of the specific IgE test apparatus 3 are exhibited.
 上記の特異的IgE検査システム1を用いた特異的IgE検査方法は、1つの検査チップに対して個別に固定化された複数項目のアレルゲンに対して、検体を接触させる工程と、検査チップにおける複数項目のアレルゲンが固定化された領域を撮像し、検体とアレルゲンとの反応を光学的に検出する工程と、光学的に検出された複数項目のアレルゲンに係る情報のうち、アレルゲンに対する特異的IgEに係る検査を行う項目を選択する工程と、選択された項目について、アレルゲンに対する特異的IgEに係る検査を行う工程と、を有する。具体的な手順について、図5を参照しながら説明する。 The specific IgE test method using the specific IgE test system 1 described above includes a step of bringing a specimen into contact with a plurality of allergens individually immobilized on one test chip, and a plurality of test chip chips. Imaging the region where the allergen of the item is immobilized, optically detecting the reaction between the specimen and the allergen, and among the information on the optically detected allergen of the plurality of items, specific IgE for the allergen The method includes a step of selecting an item to be tested, and a step of performing a test on specific IgE against allergen for the selected item. A specific procedure will be described with reference to FIG.
 まず、特異的IgE検査装置3において、ユーザ等により、検査対象の項目の選択が行われる(S01)。次に、前処理用デバイス4等を用いて、検体Oと検査チップ2とを接触させ、貫通孔21内に検体Oを導入する(S02)。これにより、検体Oと貫通孔21内のアレルゲンとが接触する。その後、検体Oが通過した後の貫通孔21内に二次抗体及び発光試薬を順に通過させることで、アレルゲンに対して反応した特異的IgEを発光させる処理を行う(S03)。 First, in the specific IgE inspection apparatus 3, an item to be inspected is selected by a user or the like (S01). Next, the specimen O and the test chip 2 are brought into contact with each other using the pretreatment device 4 or the like, and the specimen O is introduced into the through hole 21 (S02). Thereby, the sample O and the allergen in the through-hole 21 contact. Thereafter, the secondary antibody and the luminescent reagent are sequentially passed through the through-hole 21 after the specimen O has passed, thereby performing a process of emitting specific IgE reacted with the allergen (S03).
 その後、スポット領域毎に発光量が変化している検査チップ2について、特異的IgE検査装置3の撮像部31で撮像し、スポット領域毎の発光量を検出する(S04)。そして、検査部33において、検査項目設定部32において検査対象として設定された項目(アレルゲン)について、それぞれ発光量に基づいて特異的IgEの量の算出を含む特異的IgEに係る検査を行う(S05)。その後、検査結果を出力部34から出力する(S06)。これにより、特異的IgEの検査に係る一連の操作が終了する。 Thereafter, the test chip 2 in which the light emission amount changes for each spot region is imaged by the imaging unit 31 of the specific IgE inspection device 3, and the light emission amount for each spot region is detected (S04). Then, in the inspection unit 33, for the item (allergen) set as the inspection object in the inspection item setting unit 32, an inspection related to specific IgE including calculation of the amount of specific IgE based on the amount of luminescence is performed (S05). ). Thereafter, the inspection result is output from the output unit 34 (S06). Thereby, a series of operations related to the examination of specific IgE is completed.
 このように、本実施形態に係る特異的IgE検査装置によれば、検査部33によるアレルゲンに対する特異的IgEに係る検査を行う前に、検査を行う項目を検査項目設定部32において予め設定する。そして、検査部33では、検査項目設定部32において設定された項目についてのみ特異的IgEに係る検査を行うことを特徴とする。 Thus, according to the specific IgE test apparatus according to the present embodiment, the test item setting unit 32 sets the items to be tested in advance before the test unit 33 performs the test related to the specific IgE against the allergen. And in the test | inspection part 33, it test | inspects only about the specific IgE about the item set in the test | inspection item setting part 32, It is characterized by the above-mentioned.
 従来から多項目のアレルゲンに係るアレルギー診断を同時に行うことが可能なアレルギー診断薬及び装置は検討されていた。このような診断薬を用いた診断手法は、多項目のアレルゲンに係る検査を一度に行うことができるため、アレルギー疾患を有する患者の原因アレルゲンのスクリーニングに対して有用であった。 Conventionally, allergy diagnostic agents and devices capable of simultaneously performing allergy diagnosis related to multiple items of allergens have been studied. A diagnostic method using such a diagnostic agent is useful for screening causal allergens of patients with allergic diseases because it can perform tests related to allergens of multiple items at once.
 一方、特異的IgE検査を行う項目を限定して検査を行いたいというニーズも存在する。例えば、抗原のアレルゲンの候補がある程度特定されている患者については、特定されたアレルゲンのみを対象として検査を行えばよい。さらに、地域によって抗原となり得るアレルゲンが異なることも考えられる。このように、状況に応じて、特異的IgE検査を行う項目を限定して検査を行いたいというニーズが増加している。 On the other hand, there is a need to perform inspection by limiting the items for specific IgE inspection. For example, a patient whose antigen allergen candidates are specified to some extent may be examined only for the specified allergen. In addition, allergens that can be antigens vary from region to region. In this way, there is an increasing need to limit the items to be subjected to specific IgE inspection depending on the situation.
 しかしながら、ユーザの多様なニーズに応じて個別に検査チップを準備することは、検査チップの高コスト化につながる。また、患者毎のように個別に検査項目を設定することは依然として実現できないため、ユーザのニーズに対して十分に応えることは困難であった。 However, preparing individual inspection chips according to the various needs of users leads to higher costs for the inspection chips. Moreover, since it is still impossible to set the examination items individually as in each patient, it has been difficult to sufficiently satisfy the user's needs.
 これに対して、本実施形態に係る特異的IgE検査装置3を含む特異的IgE検査システム1及び特異的IgE検査方法によれば、検査部33によるアレルゲンに対する特異的IgEに係る検査を行う前に、検査を行う項目を検査項目設定部32において予め設定することが可能となる。また、検査部33では、検査項目設定部32において設定された項目についてのみアレルゲンに対する特異的IgEに係る検査を行うことができる。このように、ユーザのニーズに応じて検査項目数を変更することが可能となり、ユーザの利便性が向上する。また、検査項目が変化する場合でも、特異的IgE検査装置3側で対象の項目を選択することができるため、同一の検査チップ2を用いて検査を行うことができる。したがって、ユーザに応じて検査チップ2を製造する必要もなく、ユーザのニーズに応じて検査項目数又は検査項目を変更する構成をより低コストで実現することができる。 On the other hand, according to the specific IgE test system 1 including the specific IgE test apparatus 3 and the specific IgE test method according to the present embodiment, before the test of the specific IgE against the allergen by the test unit 33, The items to be inspected can be set in advance in the inspection item setting unit 32. In addition, the inspection unit 33 can perform an inspection related to specific IgE for allergens only for the items set in the inspection item setting unit 32. Thus, the number of inspection items can be changed according to the user's needs, and the convenience for the user is improved. Even when the inspection item changes, the target item can be selected on the side of the specific IgE inspection apparatus 3, so that the inspection can be performed using the same inspection chip 2. Therefore, it is not necessary to manufacture the inspection chip 2 according to the user, and a configuration for changing the number of inspection items or the inspection items according to the user's needs can be realized at a lower cost.
 また、検査チップ2として、上記のような厚さ方向に貫通孔21が設けられた貫流型マイクロアレイを採用することにより、複数の項目に係る検査を行うことができるチップをより単純な構成で製造することができる。また、貫流型の構成とすることで、検査チップ表面のアレルゲンと検体との間、又は、アレルゲンと検体との複合体と標識抗体と間における両者の接触機会を増やすことができ、反応を加速することができる。また、貫流型マイクロアレイの検査チップ2は、特異的IgE検査装置3の撮像部31によって、多項目のアレルゲンと検体Oとの反応結果を一度に撮像することができることから、検査をより簡便に行うことができる。 Further, by adopting a through-flow type microarray provided with the through-holes 21 in the thickness direction as described above as the inspection chip 2, a chip capable of performing inspections related to a plurality of items is manufactured with a simpler configuration. can do. In addition, the cross-flow configuration increases the chance of contact between the allergen on the surface of the test chip and the sample, or between the allergen-sample complex and the labeled antibody, thereby accelerating the reaction. can do. In addition, since the flow-through microarray test chip 2 can capture the reaction results of multiple items of allergens and the sample O at once by the imaging unit 31 of the specific IgE test apparatus 3, the test is performed more easily. be able to.
 また、上記の検査チップ2では、同一項目のアレルゲンが固定化された複数の貫通孔21により構成されるスポット領域を複数有する。同一項目のアレルゲンが固定化された貫通孔21によるスポット領域を複数有し、スポット領域毎にアレルゲンに対する特異的IgEに係る検査を行う構成とすることで、検査結果の誤りを防ぐことが可能となる。 Further, the above-described inspection chip 2 has a plurality of spot regions constituted by a plurality of through holes 21 to which allergens of the same item are immobilized. By having a plurality of spot regions by the through-holes 21 to which allergens of the same item are fixed and performing a test related to specific IgE for allergens for each spot region, it is possible to prevent test results from being erroneous. Become.
 以上、本発明をその実施形態に基づいて詳細に説明した。しかし、本発明は上記実施形態に限定されるものではない。本発明は、その要旨を逸脱しない範囲で以下のような様々な変形が可能である。 The present invention has been described in detail above based on the embodiments. However, the present invention is not limited to the above embodiment. The present invention can be modified in various ways as described below without departing from the scope of the invention.
 例えば、上記実施形態では、検査チップ2が貫流型マイクロアレイである場合について説明したが、検査チップ2の形状は適宜変更することができる。検査チップ2は、少なくとも、複数のアレルゲンが固定化されていて、検体Oとアレルゲンとが接触可能であれば、その構成は適宜変更することができる。貫流型マイクロアレイとは異なる形状で検査用チップとして用いることができる構成としては、例えば、平面の基盤に複数のアレルゲンを固定化したチップを本実施形態に係る検査用チップとして用いることが挙げられる。また、表面に凹凸を有する基盤に対して複数のアレルゲンを固定化したチップを本実施形態に係る検査用チップとして用いることもできる。 For example, in the above embodiment, the case where the inspection chip 2 is a once-through microarray has been described, but the shape of the inspection chip 2 can be changed as appropriate. The configuration of the test chip 2 can be changed as appropriate as long as at least a plurality of allergens are immobilized and the specimen O and the allergen can contact each other. As a configuration that can be used as an inspection chip in a shape different from that of the once-through microarray, for example, a chip in which a plurality of allergens are immobilized on a flat substrate is used as the inspection chip according to the present embodiment. In addition, a chip in which a plurality of allergens are immobilized on a substrate having an uneven surface can be used as the inspection chip according to the present embodiment.
 また、上記実施形態では、検査項目の設定が検査チップ2の撮像の前に行われる構成について説明したが、検査チップ2の撮像の後に検査項目の設定(選択)を行う構成としてもよい。また、検査チップ2の撮像後、スポット領域毎の発光量に係る情報を特異的IgE検査装置3で保持しておく構成とした場合には、当該情報を利用した特異的IgEに係る検査を繰り返して行うことができる。このような場合、例えば、スクリーニング段階として代表的なアレルゲンのみの評価を行い、ある程度アレルゲンと想定される物質の分野を絞ることができた段階で当該分野に係るアレルゲンに係る評価をより詳細にすることも可能となる。このように、検査項目の設定を行うタイミングは適宜変更することができる。 In the above embodiment, the configuration in which the setting of the inspection item is performed before the imaging of the inspection chip 2 has been described. However, the configuration may be such that the inspection item is set (selected) after the imaging of the inspection chip 2. In addition, after the imaging of the inspection chip 2, when the information related to the light emission amount for each spot region is held by the specific IgE inspection device 3, the inspection related to specific IgE using the information is repeated. Can be done. In such a case, for example, only a representative allergen is evaluated as a screening stage, and at a stage where the field of a substance that is assumed to be an allergen can be narrowed to some extent, the evaluation related to the allergen in the relevant field is made more detailed. It is also possible. In this way, the timing for setting the inspection item can be changed as appropriate.
 また、上記実施形態では、アレルゲンと検体Oの特異的IgEとの反応について、発光試薬を用いた発光量として測定していたが、発光試薬を用いることに代えて蛍光試薬等を利用した測定に変更してもよい。すなわち、アレルゲンと検体Oの特異的IgEとの反応は、光学的に検出することが可能な範囲で適宜変更することができる。光学的に検出する際に光源が必要となる場合には、撮像部31が光源を有する構成とすることもできる。 In the above embodiment, the reaction between the allergen and the specific IgE of the specimen O is measured as the amount of luminescence using a luminescent reagent. However, instead of using a luminescent reagent, the measurement is performed using a fluorescent reagent or the like. It may be changed. That is, the reaction between the allergen and the specific IgE of the specimen O can be appropriately changed within a range that can be detected optically. When a light source is necessary for optical detection, the imaging unit 31 may have a light source.
 1…特異的IgE検査システム、2…検査チップ、21…貫通孔、22…壁部、3…特異的IgE検査装置、31…撮像部、32…検査項目設定部、33…検査部、34…出力部。 DESCRIPTION OF SYMBOLS 1 ... Specific IgE test | inspection system, 2 ... Test chip, 21 ... Through-hole, 22 ... Wall part, 3 ... Specific IgE test | inspection apparatus, 31 ... Imaging part, 32 ... Test item setting part, 33 ... Test | inspection part, 34 ... Output part.

Claims (4)

  1.  1つの検査チップに対して個別に固定化された複数項目のアレルゲンに対して、検体を接触させる工程と、
     前記検査チップにおける前記複数項目の前記アレルゲンが固定化された領域を撮像し、前記検体と前記アレルゲンとの反応を光学的に検出する工程と、
     前記光学的に検出された前記複数項目の前記アレルゲンに係る情報のうち、前記アレルゲンに対する特異的IgEに係る検査を行う項目を選択する工程と、
     前記選択された項目について、前記アレルゲンに対する特異的IgEに係る検査を行う工程と、
     を有する特異的IgE検査方法。
    A step of bringing a specimen into contact with a plurality of allergens individually immobilized on one test chip;
    Imaging a region where the allergens of the plurality of items in the test chip are immobilized, and optically detecting a reaction between the specimen and the allergen;
    A step of selecting an item to be tested for specific IgE against the allergen among the information on the allergen of the plurality of items detected optically;
    Performing a test relating to specific IgE against the allergen for the selected item;
    A specific IgE test method comprising:
  2.  前記検査チップは、貫流型マイクロアレイである請求項1に記載の特異的IgE検査方法。 The specific IgE inspection method according to claim 1, wherein the inspection chip is a once-through microarray.
  3.  前記検査チップは、同一項目のアレルゲンが固定化された反応領域を複数有する請求項2に記載の特異的IgE検査方法。 The specific IgE test method according to claim 2, wherein the test chip has a plurality of reaction regions in which allergens of the same item are immobilized.
  4.  個別に固定化された複数項目のアレルゲンのそれぞれに対して検体を接触させた検査チップにおける前記複数項目のアレルゲンが固定化された領域を撮像し、前記検体と前記アレルゲンとの反応を光学的に検出する撮像部と、
     前記撮像部により光学的に検出された前記複数項目の前記アレルゲンに係る情報のうち、前記アレルゲンに対する特異的IgEに係る検査を行う項目を選択する検査項目設定部と、
     前記検査項目設定部により選択された項目について、前記アレルゲンに対する特異的IgEに係る検査を行う検査部と、
     を備える特異的IgE検査装置。
    An area where the plurality of allergens are immobilized on the test chip in which the specimen is brought into contact with each of the plurality of individually immobilized allergens is imaged, and the reaction between the specimen and the allergen is optically detected. An imaging unit to detect;
    A test item setting unit for selecting an item to be tested for specific IgE against the allergen among the information on the allergen of the plurality of items optically detected by the imaging unit;
    For the item selected by the test item setting unit, a test unit that performs a test related to specific IgE against the allergen;
    A specific IgE testing device comprising:
PCT/JP2016/059881 2016-03-28 2016-03-28 SPECIFIC IgE INSPECTION METHOD AND SPECIFIC IgE INSPECTION DEVICE WO2017168506A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2018507832A JPWO2017168506A1 (en) 2016-03-28 2016-03-28 Specific IgE test method and specific IgE test device
PCT/JP2016/059881 WO2017168506A1 (en) 2016-03-28 2016-03-28 SPECIFIC IgE INSPECTION METHOD AND SPECIFIC IgE INSPECTION DEVICE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2016/059881 WO2017168506A1 (en) 2016-03-28 2016-03-28 SPECIFIC IgE INSPECTION METHOD AND SPECIFIC IgE INSPECTION DEVICE

Publications (1)

Publication Number Publication Date
WO2017168506A1 true WO2017168506A1 (en) 2017-10-05

Family

ID=59963646

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/059881 WO2017168506A1 (en) 2016-03-28 2016-03-28 SPECIFIC IgE INSPECTION METHOD AND SPECIFIC IgE INSPECTION DEVICE

Country Status (2)

Country Link
JP (1) JPWO2017168506A1 (en)
WO (1) WO2017168506A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003344433A (en) * 2002-05-22 2003-12-03 Okutekku:Kk Micro-array, micro-array system and measuring method of test material
JP2010236997A (en) * 2009-03-31 2010-10-21 Panasonic Corp Microarray and biological information measurement method using the same
JP2012514184A (en) * 2008-12-29 2012-06-21 エスキューアイ ディアグノスティクス システムズ インコーポレイテッド Methods for multi-analyte detection and quantification
JP2014512535A (en) * 2011-04-18 2014-05-22 マイクロテスト マトリシーズ リミテッド Immunoassay
JP2014206460A (en) * 2013-04-12 2014-10-30 三菱レイヨン株式会社 Protein immobilization gel microarray

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003344433A (en) * 2002-05-22 2003-12-03 Okutekku:Kk Micro-array, micro-array system and measuring method of test material
JP2012514184A (en) * 2008-12-29 2012-06-21 エスキューアイ ディアグノスティクス システムズ インコーポレイテッド Methods for multi-analyte detection and quantification
JP2010236997A (en) * 2009-03-31 2010-10-21 Panasonic Corp Microarray and biological information measurement method using the same
JP2014512535A (en) * 2011-04-18 2014-05-22 マイクロテスト マトリシーズ リミテッド Immunoassay
JP2014206460A (en) * 2013-04-12 2014-10-30 三菱レイヨン株式会社 Protein immobilization gel microarray

Also Published As

Publication number Publication date
JPWO2017168506A1 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
US7217393B2 (en) Apparatus and method for process monitoring
US11293873B2 (en) Methods and devices for improved accuracy of test results
US9091699B2 (en) Microfluid testing system with a multiple-channel disc and utility thereof
JP4921458B2 (en) Screening method using polarization anisotropy in FRET emission
US9671345B2 (en) Mapping volumes of interest in selected planes in liquid samples
CN102713620B (en) In conjunction with the analysis thing quantitative multiplex microarray of inside and outside calibration method
EP4219752A1 (en) Digital molecular assays
JP2013181976A (en) Bioreaction device chip
Tan et al. Application of photonic crystal enhanced fluorescence to detection of low serum concentrations of human IgE antibodies specific for a purified cat allergen (Fel D1)
US20030119030A1 (en) Immunoassay diagnostic probe and a method for use thereof
Xia et al. The glycan array platform as a tool to identify carbohydrate antigens
JP2016510417A (en) Equipment that reduces false positives in reagent testing equipment
TW201928335A (en) Classifying microbeads in near-field imaging
JP2003149242A (en) Method of detecting antibody and antigen micro-array
WO2017168506A1 (en) SPECIFIC IgE INSPECTION METHOD AND SPECIFIC IgE INSPECTION DEVICE
JP2019113425A (en) Inspection cartridge and inspection device for immunochromatography assay
JP6457119B2 (en) Multi-unit for performing biochemical test and immune reaction test, and test method using the same
KR102127146B1 (en) A disease diagnosis information providing method and slide using plasmonic enhancement effect
US11099179B2 (en) Device and method for detecting substances present in biological or chemical samples
US20070238181A1 (en) Method and apparatus for monitoring the properties of a biological or chemical sample
KR101423588B1 (en) Multiplex Diagnostic Apparatus and Analysis Method Using the Same
US11220684B2 (en) Platform and method for identifying past exposure to chemical agents or heavy metals
EP2515271B1 (en) Method of analysing reagent beads
Bheemavarapu et al. Multi-cartridge Fluorescence Reader for Quantitative Immunoassays
US20030162178A1 (en) Variable microarray and methods of detecting one or more anlaytes in a sample

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2018507832

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16896726

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 16896726

Country of ref document: EP

Kind code of ref document: A1